Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 4 Neoplasms 2 Solid Tumors 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Genomic Instability 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Bone Neoplasms 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1

Interventions

Specimen Handling 43 pembrolizumab 42 Biopsy 36 Magnetic Resonance Spectroscopy 34 Paclitaxel 21 Carboplatin 21 Gemcitabine 20 Nivolumab 19 Irinotecan 17 Radiosurgery 15 Cisplatin 13 Taxes 11 Pemetrexed 11 Ipilimumab 11 Fluorouracil 11 Cetuximab 11 trastuzumab deruxtecan 10 olaparib 10 Leucovorin 10 130-nm albumin-bound paclitaxel 10 abemaciclib 9 Oxaliplatin 9 Cyclophosphamide 9 Capecitabine 9 Bevacizumab 9 palbociclib 8 durvalumab 8 Fulvestrant 8 X-Rays 7 Trastuzumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × alectinib × 90 days × Clear all

NCT04116541 2026-04-24

MegaMOST

Centre Leon Berard

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡